950 related articles for article (PubMed ID: 24140417)
1. First hospitalization for heart failure in France in 2009: patient characteristics and 30-day follow-up.
Tuppin P; Cuerq A; de Peretti C; Fagot-Campagna A; Danchin N; Juillière Y; Alla F; Allemand H; Bauters C; Drici MD; Hagège A; Jondeau G; Jourdain P; Leizorovicz A; Paccaud F
Arch Cardiovasc Dis; 2013 Nov; 106(11):570-85. PubMed ID: 24140417
[TBL] [Abstract][Full Text] [Related]
2. Two-year outcome of patients after a first hospitalization for heart failure: A national observational study.
Tuppin P; Cuerq A; de Peretti C; Fagot-Campagna A; Danchin N; Juillière Y; Alla F; Allemand H; Bauters C; Drici MD; Hagège A; Jondeau G; Jourdain P; Leizorovicz A; Paccaud F
Arch Cardiovasc Dis; 2014 Mar; 107(3):158-68. PubMed ID: 24662470
[TBL] [Abstract][Full Text] [Related]
3. Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey.
Cohen Solal A; Leurs I; Assyag P; Beauvais F; Clerson P; Contre C; Thebaut JF; Genoun M;
Arch Cardiovasc Dis; 2012; 105(6-7):355-65. PubMed ID: 22800720
[TBL] [Abstract][Full Text] [Related]
4. Long-term trends of angiotensin-converting enzyme inhibitor and angiotensin-receptor blocker use after heart failure hospitalization in community-dwelling seniors.
Setoguchi S; Levin R; Winkelmayer WC
Int J Cardiol; 2008 Apr; 125(2):172-7. PubMed ID: 17997175
[TBL] [Abstract][Full Text] [Related]
5. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
Sun SX; Ye X; Lee KY; Dupclay L; Plauschinat C
Clin Ther; 2008; 30 Pt 2():2217-27. PubMed ID: 19281916
[TBL] [Abstract][Full Text] [Related]
6. Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
O'Connor CM; Abraham WT; Albert NM; Clare R; Gattis Stough W; Gheorghiade M; Greenberg BH; Yancy CW; Young JB; Fonarow GC
Am Heart J; 2008 Oct; 156(4):662-73. PubMed ID: 18926148
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker adherence in patients with primary versus secondary diagnosis of heart failure.
Brackbill ML; Bashaw-Keaton R; Sytsma CS
Am J Manag Care; 2007 Oct; 13(10):568-70. PubMed ID: 17927461
[TBL] [Abstract][Full Text] [Related]
8. [Characteristics and prevention among patients with stroke: a study of 36,844 patients hospitalized in France].
Tuppin P; Moysan V; de Peretti C; Schnitzler A; Fery-Lemonnier E; Woimant F
Rev Neurol (Paris); 2013 Feb; 169(2):126-35. PubMed ID: 22749335
[TBL] [Abstract][Full Text] [Related]
9. Management and 2-year follow-up of children aged 29 days to 17 years hospitalized for a first stroke in France (2009-2010).
Tuppin P; Samson S; Woimant F; Chabrier S
Arch Pediatr; 2014 Dec; 21(12):1305-15. PubMed ID: 25287139
[TBL] [Abstract][Full Text] [Related]
10. Does aspirin use adversely influence intermediate-term postdischarge outcomes for hospitalized patients who are treated with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers? Findings from Organized Program to Facilitate Life-Saving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
Levy PD; Nandyal D; Welch RD; Sun JL; Pieper K; Ghali JK; Fonarow GC; Gheorghiade M; O'Connor CM
Am Heart J; 2010 Feb; 159(2):222-230.e2. PubMed ID: 20152220
[TBL] [Abstract][Full Text] [Related]
11. Effects of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy after hospital discharge on subsequent rehospitalization for acute myocardial infarction and heart failure.
Hess G; Preblick R; Hill J; Plauschinat CA; Yaskin J
Congest Heart Fail; 2009; 15(4):170-5. PubMed ID: 19627290
[TBL] [Abstract][Full Text] [Related]
12. A review of heart failure management in the elderly population.
Cheng JW; Nayar M
Am J Geriatr Pharmacother; 2009 Oct; 7(5):233-49. PubMed ID: 19948300
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics and outcomes of hospitalized heart failure patients with systolic dysfunction and chronic obstructive pulmonary disease: findings from OPTIMIZE-HF.
Mentz RJ; Fiuzat M; Wojdyla DM; Chiswell K; Gheorghiade M; Fonarow GC; O'Connor CM
Eur J Heart Fail; 2012 Apr; 14(4):395-403. PubMed ID: 22302663
[TBL] [Abstract][Full Text] [Related]
14. Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial.
Gattis WA; O'Connor CM; Gallup DS; Hasselblad V; Gheorghiade M;
J Am Coll Cardiol; 2004 May; 43(9):1534-41. PubMed ID: 15120808
[TBL] [Abstract][Full Text] [Related]
15. Discharge use of angiotensin receptor blockers provides comparable effects with angiotensin-converting enzyme inhibitors on outcomes in patients hospitalized for heart failure.
Tsuchihashi-Makaya M; Furumoto T; Kinugawa S; Hamaguchi S; Goto K; Goto D; Yamada S; Yokoshiki H; Takeshita A; Tsutsui H;
Hypertens Res; 2010 Mar; 33(3):197-202. PubMed ID: 19960016
[TBL] [Abstract][Full Text] [Related]
16. Evidence-based pharmacotherapies used in the postdischarge phase are associated with improved one-year survival in senior patients hospitalized with heart failure.
Qin X; Hung J; Knuiman M; Teng TK; Briffa T; Sanfilippo FM
Cardiovasc Ther; 2018 Dec; 36(6):e12464. PubMed ID: 30126048
[TBL] [Abstract][Full Text] [Related]
17. N-terminal pro-B-type natriuretic peptide-guided, intensive patient management in addition to multidisciplinary care in chronic heart failure a 3-arm, prospective, randomized pilot study.
Berger R; Moertl D; Peter S; Ahmadi R; Huelsmann M; Yamuti S; Wagner B; Pacher R
J Am Coll Cardiol; 2010 Feb; 55(7):645-53. PubMed ID: 20170790
[TBL] [Abstract][Full Text] [Related]
18. Effect of statins, angiotensin-converting enzyme inhibitors, and beta blockers on survival in patients >or=65 years of age with heart failure and preserved left ventricular systolic function.
Shah R; Wang Y; Foody JM
Am J Cardiol; 2008 Jan; 101(2):217-22. PubMed ID: 18178410
[TBL] [Abstract][Full Text] [Related]
19. Carvedilol use at discharge in patients hospitalized for heart failure is associated with improved survival: an analysis from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
Fonarow GC; Abraham WT; Albert NM; Stough WG; Gheorghiade M; Greenberg BH; O'Connor CM; Sun JL; Yancy C; Young JB;
Am Heart J; 2007 Jan; 153(1):82.e1-11. PubMed ID: 17174643
[TBL] [Abstract][Full Text] [Related]
20. Renin-Angiotensin System Inhibition and Lower 30-Day All-Cause Readmission in Medicare Beneficiaries with Heart Failure.
Sanam K; Bhatia V; Bajaj NS; Gaba S; Morgan CJ; Fonarow GC; Butler J; Deedwania P; Prabhu SD; Wu WC; White M; Love TE; Aronow WS; Fletcher RD; Allman RM; Ahmed A
Am J Med; 2016 Oct; 129(10):1067-73. PubMed ID: 27262781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
